1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY, CA
Market cap: $3.4B (2/09/2026)
Price: $38.19
Amendment to Exclusive Option and License Agreement with Hansoh
Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference
Announces Pricing of Upsized $650 Million Public Offering
Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701’s Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting
Earnings Release
Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML
Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist in Obesity
Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership